Good AI Practice in drug development
2026 January 14
The US Food and Drug Administration (FDA) has collaborated with the European Medicines Agency (EMA) to develop 10 guiding principles of good AI practice in drug development that industry and product developers can consider when using artificial intelligence (AI) to advance the development of drugs and biological products.